NEW YORK, April 30 - Compugen said Monday its first-quarter net revenues increased to $2.2 million for the quarter, compared with $859,000 in the year-ago period as the Tel Aviv-based company posted growing sales for its proteomics technology and Gencarta database.

NEW YORK, April 30 – DoubleTwist said Monday that the Max Planck Institute of Biophysical Chemistry in Gottingen, Germany has signed up for DoubleTwist.com, giving the institute access to the Annotated Human Genome Database and Annotated Human and Mouse Gene Indices.

NEW YORK, April 30 – Caliper Technologies of Mountain View, Calif., said Monday its first-quarter revenues surged as a result of increased licensing fees and product sales. The company, which makes lab-on-a-chip technology, said its fir

NEW YORK, April 30 - Genomica said Monday it would develop a “Celera Edition” of its Discovery Manager software to work in conjunction with Celera’s SNP Reference Database. Genomica of Boulder, Colo., did not disclose financial terms of the de

  NEW YORK, April 30 – Beckman Coulter’s first quarter revenues slipped 0.4 percent to $432.7 million, compared with $434.4 million a year ago, due to unfavorable exchange rates. On a constant currency basis, sales rose 6.

NEW YORK, April 30 - Nanogen has appointed Gerald Wills, formerly the chief financial officer of Trega Biosciences, as its vice president and chief financial officer, the San Diego-based company said Monday. Wills, 48, will replace the current CFO Kieran Gallahue, who will now work s

NEW YORK, April 30 - Driven by four new subscriptions to its GeneExpress database, Gene Logic reported a 54 percent increase in first quarter 2001 revenues to $8.2 million, compared with $5.3 million in the year ago quarter. "The company's progress on all fronts is consistent with our

NEW YORK, April 30 - Vertex Pharmaceuticals has agreed to acquire Aurora Biosciences in a stock-for-stock deal worth $592 million, the companies said Monday. The deal is designed to help Vertex expand its drug discovery progra

NEW YORK, April 30 – Nanogen said Monday its first quarter revenues jumped 26 percent to $2.9 million, compared with $2.3 million in the year ago quarter, as revenues from sponsored corporate and government research programs and sales of its NanoChip Molecular Biology Wor

NEW YORK, April 27 - Myriad Genetics made a splash earlier this month when it announced a collaboration with Hitachi and Oracle to "map the human proteome" by 2004. The scope of this ambitious task could vary widely,

Backed by a one-year, $100,000 SBIR grant from the National Institutes for General Medical Sciences, Cognia is embarking on the development of a protein catabolism database and software system, its first in-house commercial offering.

OmniViz, a Battelle spinoff, is counting on its data visualization software to help scientists transform information overload into knowledge. While its competitors allow researchers to test connections between attributes, OmniViz Pro lets them explore multiple data sets and discover unexpected relationships, said Jeff Saffer, chief technology officer.

IT'S A bear’s holiday; they are roaming freely on Wall Street. Occasionally, a bull pokes its head out and makes a run for it. But he goes it alone, no thundering herds! The current situation may have forced you to delay raising capital, opting instead to wait for the market to recover.

As part of a new reporting structure, Cellomics of Pittsburgh has hired three new members of its senior management team.

TurboGenomics of New Haven, Conn., has released the latest version of TurboBlast, an accelerated, parallel implementation of the Blast sequence comparison tool.

NEW YORK, April 27 – Following a trend that is becoming common on Wall Street these days, Packard Bioscience has withdrawn a planned follow-on offering of 10 million shares of its common stock, the company said Friday. This announcement

NEW YORK, April 27 – Exelixis and AVI BioPharma have agreed to partner in a drug development alliance using Exelixis’ zebrafish functional genomics technologies and AVI’s antisense agents, the companies said Friday. In a five-year agree

NEW YORK, April 27 - Celera said Friday it had completed its final assembly of the mouse genome, and has now begun annotating the assembled genome. Celera's assembly, which it achieved using its whole genome shotgun method

TOKYO, April 27 –  As Japan lunges full blast into its government-supported genomics efforts, Western genomics companies have lately been showing signs they are turning eastward to seize the new market opportunities. Tuesday,

DoubleTwist said it has acquired the exclusive rights to license the Weizmann Institute s GeneCards database to commercial entities.

AT A GLANCE: BSc in paleontology and zoology from the University of Wales, MSc in biochemistry from the University of Kent at Canterbury, PhD in molecular biology from the University of Edinburgh.

Partek has added its Partek Pro 2000 statistical and visual analysis software to a growing list of software tools to be integrated with Gene Logic s software platform for its GeneExpress suite of databases.

IBM and NetGenics have expanded their partnership to include an agreement for NetGenics to resell IBM s DiscoveryLink.

GeneProt said the large-scale proteomics discovery center it opened last week in Geneva, Switzerland, is supported by the world s most powerful commercial supercomputer.

While delivering his paper on normalized sequence alignment at Recomb 2001, Pavel Pevzner noted that Temple Smith and Michael Waterman were not the first to address the problem of sequence alignment, but they were the first to get the question right in order to resolve it with their famous algorithm.